课题基金 / 基金详情

Transitioning Electronic Support for Public Health (ESP) from Lab to Marketplace

Transitioning Electronic Support for Public Health (ESP) from Lab to Marketplace
将公共卫生电子支持 (ESP) 从实验室转变为市场
批准号:
8919742
负责人:
DAVID M FRAM
金额:
$33.38万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-01 至 2016-07-31

项目摘要

项目成果

DAVID M FRAM的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):准确和完整的疾病监测对于使公共卫生当局能够检测和应对疾病暴发、流行病,甚至生物恐怖主义事件至关重要。虽然法律要求医疗从业者和做法,但大多数应报告的疾病仍然是手动或通过有限的自动化实验室检测结果报告。这给从业人员造成了很大的负担,产生的数据稀少,不符合负责保护公共健康的机构的全部要求。为了解决报告和监测方面的局限性,疾病控制和预防中心从2005年开始赞助了一个项目,以开发和试验一个开放源代码的电子系统(称为公共卫生支持,或ESP),以利用编码到电子健康记录(EHR)系统中的丰富信息,自动检测和报告应报告的疾病。合作机构包括哈佛医学院、哈佛先锋医学协会和马萨诸塞州公共卫生部。CDC和AHRQ随后资助创建了更多的原型,用于症状监测、慢性病流行监测、疫苗不良事件的自动检测和报告,以及将ESP作为加强监测性传播疾病的工具。我们相信,ESP是NIH实验室到市场(用于生物医学和行为研究的工具)SBIR征集的近乎完美的基础。它代表着先进的、被证明是有用的技术,这些技术是用国土安全部的巨额投资开发的,但到目前为止只在少数几个机构使用。作为一种持续、可行的商业活动,电除尘器永远不会实现“起飞”,这是一个真正的危险。该项目的总体目标是实现电除尘器的全部功能潜力,使其更健壮和更容易 使用和部署,并采取必要步骤,使其走上更广泛部署的道路。具体地说,该项目将利用新兴的医疗数据标准,提高ESP在整个EHR系统中的可移植性,并减少医疗实践在设置和使用ESP以及访问系统捕获的数据方面的维护和管理负担。作为加强疾病检测的一个有利组成部分,该项目还包括为自由文本实验室微生物学报告开发一个自动化处理模块。利用这一基础,该项目将大大扩展在电除尘器内检测到的疾病集,并完成上述现有的原型电除尘器能力。该项目涉及与领导ESP最初开发工作的组织(哈佛人口医学部)的专家以及俄亥俄州东北部的MetroHealth System密切合作,MetroHealth System是一家地区性医疗保健提供商,自2009年以来一直在生产ESP。
英文摘要
DESCRIPTION (provided by applicant): Accurate and complete disease surveillance is critical to enable public health authorities to detect and respond to disease outbreaks, epidemics, and even bioterrorism events. While legally required of healthcare practitioners and practices, most notifiable disease reporting is still done manually or through limited automated laboratory test result reporting. This creates a substantial burden on practitioners and produces sparse data that does not meet the full requirements of the agencies responsible for protecting public health. To address limitations in reporting and surveillance, the Centers for Disease Control and Prevention, beginning in 2005, sponsored a project to develop and pilot an open-source electronic system (called EHR Support for Public Health, or ESP) to automate the detection and reporting of notifiable diseases by taking advantage of the rich information coded into electronic health record (EHR) systems. Collaborating institutions included Harvard Medical School, Harvard Vanguard Medical Associates, and the Massachusetts Department of Public Health. CDC and AHRQ subsequently funded the creation of additional prototypes for syndromic surveillance, chronic disease prevalence monitoring, and automated detection and reporting of vaccine adverse events, as well as the fielding of ESP as a vehicle for enhanced surveillance of sexually transmitted diseases. We believe that ESP is a near-perfect basis for the NIH's Lab to Marketplace (Tools for Biomedical and Behavioral Research) SBIR solicitation. It represents advanced, proven-to-be-useful technology that was developed with substantial DHHS investment, but it is only in use so far at a handful of institutions. There is a real danger that ESP will never attain "lift-off" as a sustained, viable commercial activity. The overall goalsof this project are to realize the full functional potential of ESP, to make it more robust and easier to use and deploy, and to take the necessary steps to move it onto a pathway to wider deployment. Specifically, the project will take advantage of emerging healthcare data standards to increase portability of ESP across EHR systems and to reduce the maintenance and management burden on healthcare practices for the setup and use of ESP and for access to the data captured by the system. As an enabling component for enhancing disease detection, the project also includes the development of an automated processing module for free-text laboratory microbiology reports. Utilizing this foundation, the project will significantly extend te set of diseases detected within ESP and complete the existing prototype ESP capabilities mentioned above. The project involves close collaboration with experts at the organization (the Harvard Department of Population Medicine) that led the original development work on ESP as well as with the MetroHealth System of Northeast Ohio, a regional healthcare provider that has been running ESP on a production basis since 2009.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transitioning Electronic Support for Public Health (ESP) from Lab to Marketplace
  • 批准号:
    8781524
  • 项目类别:
  • 资助金额:
    $34.39万
  • 财政年份:
    2014
  • 负责人:
    DAVID M FRAM
  • 依托单位:
Safety Data Mining Based on Chemical Structures
  • 批准号:
    6865093
  • 项目类别:
  • 资助金额:
    $17.95万
  • 财政年份:
    2005
  • 负责人:
    DAVID M FRAM
  • 依托单位:
Discriminating Drug Safety Profiles in Polytherapy
  • 批准号:
    6738316
  • 项目类别:
  • 资助金额:
    $9.97万
  • 财政年份:
    2004
  • 负责人:
    DAVID M FRAM
  • 依托单位:
Next-Generation Safety Data Mining System
  • 批准号:
    6549272
  • 项目类别:
  • 资助金额:
    $8.59万
  • 财政年份:
    2002
  • 负责人:
    DAVID M FRAM
  • 依托单位:
海外基金